CRON
Cronos Group·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Ample Liquidity
Significant Net Income Growth
Revenue Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CRON
Cronos Group Inc.
A Canadian producer of medical marijuana and cannabis oils
4491 Concession Rd 12, Stayner, Ontario L0M 1S0
--
Cronos Group Inc. (" Cronos "or the" Company ") was incorporated on August 21, 2012 under the Business Corporations Act (Ontario) at 2339498 Ontario Inc., and changed its name to Searchtech Ventures Inc. "Searchtech" on October 18, 2012, And is defined as a capital pool company in accordance with policy 2.4 of the TSX Venture Exchange (" TSX-V "). The Cronos Group was formed to develop an application based on a capitalized company that is applying to Health Canada to become a licensed producer of medical cannabis.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS0.02
Estimate Revenue31.58M
Actual Revenue32.26M
Contradictions Unveiled: Cronos Group's 2025 Q1 Earnings Call Highlights Product Shortages, GrowCo Expansion, and Margin Expectations
May 19,2025 06:20
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS-0.1
Estimate Revenue33.28M
Actual Revenue33.46M
Cronos Group's Q2 2025: Unpacking Contradictions in Gross Margins, GrowCo Expansion, and Market Performance
Aug 07,2025 10:38
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
CRON has released its 2025 Q3 earnings. EPS was reported at 0.07, versus the expected 0, beating expectations. The chart below visualizes how CRON has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CRON has released its 2025 Q3 earnings report, with revenue of 36.34M, reflecting a YoY change of 6.06%, and net profit of 28.32M, showing a YoY change of 286.69%. The Sankey diagram below clearly presents CRON's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
